Search Results for “EU” – Page 404 – media

Trillion in search of new partners

Trillium Therapeutics is seeking new partners as it looks over its pipeline with an eye to the future.
- Source: fiercebiotech
- 755
- July 5, 2017
EMA EU Market Views
MPs keen for close collaboration with EMA post Brexit

British MPs say they are keen to secure a close working relationship with the European Union on drug regulation post Brexit to protect patient health and investment in the UK’s life sciences sector.
- Source: pharmatimes
- 846
- July 4, 2017
Company Insight EMA EU
How to Develop The Indonesian Market?

It is a common problem that concerned us. As a global pharmaceuticals and medical devices B2B online platform, Ddu invited Sherlock Chen, a senior biotech practitioner, to talk about how to develop the Indonesian market.
- Source: Ddu
- 983
- July 2, 2017
ACTD Halal Indonesian Market Reports
Drugdu.com (“Ddu”) to attend the PHAR-MED EXPO 2017

The 5th Myanmar International Medical Equipment, Hospital and Pharmaceutical Exhibition (PHAR-MED EXPO 2017) will be held in Myanmar's capital, Yangon, during July 5 - 7, 2017. Drugdu.com(“Ddu”), the first global pharmaceuticals and medical devices B2B online platform, will be participating in the exhibition to showcase the new method of cross-border medical trade from China.
- Source: Ddu
- 404
- July 1, 2017
Exhibitions & Activities
Novartis bags first-line approval for Zykadia

The European Commission has expanded the scope of Novartis’ Zykadia to include the first line treatment of patients with non-small cell lung cancer (NSCLC) whose tumours are anaplastic lymphoma kinase (ALK)-positive.
- Source: pharmatimes
- 494
- June 30, 2017
cancer Company Insight New Approvals NSCLC Zykadia
GSK tests mepolizumab for nasal polyps

GlaxoSmithKline has kicked off a Phase III study exploring the potential of its biologic mepolizumab in patients with severe bilateral nasal polyps, a chronic inflammatory disease of the nasal passage linings or sinuses causing soft tissue growth in the upper nasal cavity.
- Source: Pharmtimes
- 783
- June 28, 2017
Clinical Trials EU mepolizumab
GSK tests mepolizumab for nasal polyps

GlaxoSmithKline has kicked off a Phase III study exploring the potential of its biologic mepolizumab in patients with severe bilateral nasal polyps, a chronic inflammatory disease of the nasal passage linings or sinuses causing soft tissue growth in the upper nasal cavity.
- Source: pharmatimes
- 757
- June 28, 2017
asthma Company Insight EU surgery
Global Hemodialysis Consumables Market Analysis

As the most potential market in china, Hemodialysis market appears a large revenue space. With the opening of private hemodialysis services, private economy in the hemodialysis industry is about to take a ”Golden era”.
- Source: Ddu
- 591
- June 24, 2017
hemodialysis consumables Market Reports
US nod for CSL Behring’s HAE prevention therapy

US regulators have approved CSL Behring’s Haegarda, the first C1 esterase inhibitor for subcutaneous administration to prevent hereditary (HAE) attacks in adolescent and adults.
- Source: pharmatimes
- 433
- June 23, 2017
HAE inhibitor New Approvals
Ddu’s Golden Age in Cross-border Medical Trade

Under the background of the Internet plus era, Ddu is set up by a a talented team, consisting of experienced insiders and Internet elites. Ddu (Drugdu.com) is a global leading pharmaceuticals and medical devices B2B online platform. Different from comprehensive B2B platforms, Ddu is a vertical one focusing on the medical trade industry. It is a bold attempt for traditional industry to accelerate the transformation and upgrading.
- Source: Ddu
- 705
- June 22, 2017
cross-border medical device pharmaceutical

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.